vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Sinclair, Inc. (SBGI). Click either name above to swap in a different company.

Sinclair, Inc. is the larger business by last-quarter revenue ($807.0M vs $487.7M, roughly 1.7× CLOVER HEALTH INVESTMENTS, CORP.). Sinclair, Inc. runs the higher net margin — 2.5% vs -10.1%, a 12.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 4.0%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -1.3%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Sinclair, Inc., doing business as Sinclair Broadcast Group, is a publicly traded American telecommunications conglomerate that is controlled by the descendants of company founder Julian Sinclair Smith. Headquartered in the Baltimore suburb of Cockeysville, Maryland, the company is the second-largest television station operator in the United States by number of stations after Nexstar Media Group, owning or operating 193 stations across the country in over 100 markets, covering 40% of American ...

CLOV vs SBGI — Head-to-Head

Bigger by revenue
SBGI
SBGI
1.7× larger
SBGI
$807.0M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+40.7% gap
CLOV
44.7%
4.0%
SBGI
Higher net margin
SBGI
SBGI
12.6% more per $
SBGI
2.5%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-1.3%
SBGI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
SBGI
SBGI
Revenue
$487.7M
$807.0M
Net Profit
$-49.3M
$20.0M
Gross Margin
Operating Margin
-10.1%
0.0%
Net Margin
-10.1%
2.5%
Revenue YoY
44.7%
4.0%
Net Profit YoY
-123.2%
EPS (diluted)
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SBGI
SBGI
Q1 26
$807.0M
Q4 25
$487.7M
$836.0M
Q3 25
$496.6M
$773.0M
Q2 25
$477.6M
$784.0M
Q1 25
$462.3M
$776.0M
Q4 24
$337.0M
$1.0B
Q3 24
$331.0M
$917.0M
Q2 24
$356.3M
$829.0M
Net Profit
CLOV
CLOV
SBGI
SBGI
Q1 26
$20.0M
Q4 25
$-49.3M
$109.0M
Q3 25
$-24.4M
$-1.0M
Q2 25
$-10.6M
$-64.0M
Q1 25
$-1.3M
$-156.0M
Q4 24
$-22.1M
$176.0M
Q3 24
$-9.2M
$94.0M
Q2 24
$7.4M
$17.0M
Gross Margin
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
SBGI
SBGI
Q1 26
0.0%
Q4 25
-10.1%
9.6%
Q3 25
-4.9%
7.5%
Q2 25
-2.2%
2.7%
Q1 25
-0.3%
1.8%
Q4 24
-6.4%
26.5%
Q3 24
-2.7%
19.5%
Q2 24
2.0%
7.7%
Net Margin
CLOV
CLOV
SBGI
SBGI
Q1 26
2.5%
Q4 25
-10.1%
13.0%
Q3 25
-4.9%
-0.1%
Q2 25
-2.2%
-8.2%
Q1 25
-0.3%
-20.1%
Q4 24
-6.6%
17.5%
Q3 24
-2.8%
10.3%
Q2 24
2.1%
2.1%
EPS (diluted)
CLOV
CLOV
SBGI
SBGI
Q1 26
$0.28
Q4 25
$1.62
Q3 25
$-0.02
Q2 25
$-0.91
Q1 25
$-2.30
Q4 24
$2.64
Q3 24
$1.43
Q2 24
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SBGI
SBGI
Cash + ST InvestmentsLiquidity on hand
$78.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
Total Assets
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
$78.3M
$866.0M
Q3 25
$526.0M
Q2 25
$616.0M
Q1 25
$631.0M
Q4 24
$194.5M
$697.0M
Q3 24
$288.0M
$536.0M
Q2 24
$254.8M
$378.0M
Total Debt
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
$4.4B
Q3 25
$4.1B
Q2 25
$4.1B
Q1 25
$4.2B
Q4 24
$4.1B
Q3 24
$4.1B
Q2 24
$4.1B
Stockholders' Equity
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
$308.7M
$443.0M
Q3 25
$340.9M
$347.0M
Q2 25
$344.2M
$361.0M
Q1 25
$336.1M
$436.0M
Q4 24
$341.1M
$583.0M
Q3 24
$342.2M
$415.0M
Q2 24
$324.9M
$340.0M
Total Assets
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
$541.0M
$5.9B
Q3 25
$559.7M
$5.6B
Q2 25
$575.0M
$5.7B
Q1 25
$583.7M
$5.8B
Q4 24
$580.7M
$5.9B
Q3 24
$653.0M
$5.8B
Q2 24
$674.2M
$5.7B
Debt / Equity
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
9.84×
Q3 25
11.75×
Q2 25
11.30×
Q1 25
9.56×
Q4 24
7.02×
Q3 24
9.86×
Q2 24
12.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SBGI
SBGI
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
1.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
$-66.9M
$98.0M
Q3 25
$12.1M
$-36.0M
Q2 25
$5.4M
$122.0M
Q1 25
$-16.3M
$5.0M
Q4 24
$34.8M
$198.0M
Q3 24
$50.0M
$210.0M
Q2 24
$44.8M
$-306.0M
Free Cash Flow
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
$-69.0M
$79.0M
Q3 25
$11.4M
$-58.0M
Q2 25
$4.8M
$105.0M
Q1 25
$-16.5M
$-11.0M
Q4 24
$33.3M
$175.0M
Q3 24
$49.6M
$193.0M
Q2 24
$44.4M
$-329.0M
FCF Margin
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
-14.1%
9.4%
Q3 25
2.3%
-7.5%
Q2 25
1.0%
13.4%
Q1 25
-3.6%
-1.4%
Q4 24
9.9%
17.4%
Q3 24
15.0%
21.0%
Q2 24
12.5%
-39.7%
Capex Intensity
CLOV
CLOV
SBGI
SBGI
Q1 26
1.7%
Q4 25
0.4%
2.3%
Q3 25
0.1%
2.8%
Q2 25
0.1%
2.2%
Q1 25
0.0%
2.1%
Q4 24
0.5%
2.3%
Q3 24
0.1%
1.9%
Q2 24
0.1%
2.8%
Cash Conversion
CLOV
CLOV
SBGI
SBGI
Q1 26
Q4 25
0.90×
Q3 25
Q2 25
Q1 25
Q4 24
1.13×
Q3 24
2.23×
Q2 24
6.04×
-18.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

SBGI
SBGI

Media revenue$701.0M87%
Other$82.0M10%
Political advertising revenue$18.0M2%
Non-media revenue$6.0M1%

Related Comparisons